David Ball1. 1. Institute of Psychiatry, King's College London, De Crespigny Park, London, UK. d.ball@iop.kcl.ac.uk
Abstract
AIM: To assess the progress and impact of genetic studies in the addictions arena and to present this information in a form accessible to the general readership of Addiction. METHODS: Review of the evidence that genes are involved in addiction, approaches to their identification, current findings and the potential implications. RESULTS: Family, twin and adoption studies provide strong evidence that addiction runs in families and that this is determined in part by genetic factors. Two main molecular genetic approaches, namely linkage and association, have been adopted to identify the specific genes involved. Both methods are fraught with problems. Linkage is limited by issues of sensitivity, and association by false positives. Perhaps the strongest finding in psychiatric genetics to date is the impressive effect that a single genetic variant, in the aldehyde dehydrogenase 2 gene, has on drinking behaviour and reducing the risk of developing alcohol dependence. Other findings are currently less robust; however, the implications of elucidating the genetic underpinning of addiction will be profound. CONCLUSIONS: Addiction genetics is a developing science that has yet to prove its worth in the clinical setting.
AIM: To assess the progress and impact of genetic studies in the addictions arena and to present this information in a form accessible to the general readership of Addiction. METHODS: Review of the evidence that genes are involved in addiction, approaches to their identification, current findings and the potential implications. RESULTS: Family, twin and adoption studies provide strong evidence that addiction runs in families and that this is determined in part by genetic factors. Two main molecular genetic approaches, namely linkage and association, have been adopted to identify the specific genes involved. Both methods are fraught with problems. Linkage is limited by issues of sensitivity, and association by false positives. Perhaps the strongest finding in psychiatric genetics to date is the impressive effect that a single genetic variant, in the aldehyde dehydrogenase 2 gene, has on drinking behaviour and reducing the risk of developing alcohol dependence. Other findings are currently less robust; however, the implications of elucidating the genetic underpinning of addiction will be profound. CONCLUSIONS: Addiction genetics is a developing science that has yet to prove its worth in the clinical setting.
Authors: Josef Frank; Sven Cichon; Jens Treutlein; Monika Ridinger; Manuel Mattheisen; Per Hoffmann; Stefan Herms; Norbert Wodarz; Michael Soyka; Peter Zill; Wolfgang Maier; Rainald Mössner; Wolfgang Gaebel; Norbert Dahmen; Norbert Scherbaum; Christine Schmäl; Michael Steffens; Susanne Lucae; Marcus Ising; Bertram Müller-Myhsok; Markus M Nöthen; Karl Mann; Falk Kiefer; Marcella Rietschel Journal: Addict Biol Date: 2011-10-18 Impact factor: 4.280
Authors: Bridget F Grant; Risë B Goldstein; Tulshi D Saha; S Patricia Chou; Jeesun Jung; Haitao Zhang; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin Journal: JAMA Psychiatry Date: 2015-08 Impact factor: 21.596
Authors: Joanna M Biernacka; Jennifer Geske; Gregory D Jenkins; Colin Colby; David N Rider; Victor M Karpyak; Doo-Sup Choi; Brooke L Fridley Journal: Int J Neuropsychopharmacol Date: 2012-05-02 Impact factor: 5.176
Authors: Huiping Zhang; Aryeh I Herman; Henry R Kranzler; Raymond F Anton; Hongyu Zhao; Wei Zheng; Joel Gelernter Journal: Alcohol Clin Exp Res Date: 2012-08-24 Impact factor: 3.455